An improved procedure for quantitation of platelet factor 4.
Platelet factor 4 (heparin neutralizing) activity shortens the thrombin time of a heparinized plasma. In the proposed procedure (I) a heparin thrombin time curve is constructed by adding gradually increasing amounts of heparin to a commercial plasma substrate and determining thrombin times, (2) a suitable concentration of heparin that gives highest reproducible thrombin time is selected and added to the substrate, (3) thrombin times are determined for the heparinized substrate before and after addition of a test material containing platelet factor 4. The two thrombin times are converted to heparin concentration by reference to the heparin thrombin time curve. The difference in heparin concentrations represents platelet factor 4 activity. When lyophilized commercial plasma is used as substrate larger quantities of heparin can be employed in the system, resulting in improved sensitivity and precision.
D001779:Blood Coagulation Factors / Q000032:analysis*; D001780:Blood Coagulation Tests / Q000379:methods*; D005069:Evaluation Studies as Topic; D006493:Heparin; D006801:Humans; D007202:Indicators and Reagents; D010978:Platelet Factor 4 / Q000032:analysis*; D013010:Sonication; D013917:Thrombin
D001779:Blood Coagulation Factors; D007202:Indicators and Reagents; D010978:Platelet Factor 4; D006493:Heparin; D013917:Thrombin